Procainamide Hydrochloride
- Product NDC
- 68083-604
- Requested package NDC
- 68083-604-25
- 11-digit product format
- 680830604
- Labeler code
- 68083
- Product ID
- 68083-604_e8e25e4b-14ce-40cb-85d9-4cc78ca9e807
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Procainamide Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Gland Pharma Limited
- Application
- ANDA218135
- Marketing category
- ANDA
- Marketing start
- 2024-07-22
- Substance
- PROCAINAMIDE HYDROCHLORIDE
- Active strength
- 500 mg/mL
- Pharmacologic classes
- Antiarrhythmic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218135-001 | PROCAINAMIDE HYDROCHLORIDE | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | RS | 2024-07-22 |
| A218135-002 | PROCAINAMIDE HYDROCHLORIDE | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | RS | 2024-07-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218135-001 | AP |
| A218135-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | RS | 2024-07-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | RS | 2024-07-22 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | RS | 2024-07-22 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | RS | 2024-07-22 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | RS | 2024-07-22 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | RS | 2024-07-22 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | 2024-07-22 | 79d66fd596c7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218135-001 | PROCAINAMIDE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | RS | 2024-07-22 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218135-002 | PROCAINAMIDE HYDROCHLORIDE | 500MG/ML | INJECTABLE / INJECTION | AP | RS | 2024-07-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218135-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218135-002 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218135-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218135-002 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218135-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218135-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218135-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218135-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A218135-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A218135-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218135-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218135-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218135-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218135-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218135-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218135-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218135-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218135-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218135-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218135-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218135-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218135-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A218135-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A218135-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218135-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218135-002 | AP | 1 | 79d66fd596c7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218135-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218135-002 | AP | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Procainamide Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PROCAINAMIDE HYDROCHLORIDE | 500 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| SI4064O0LX | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ffde440f-7ad7-434c-bcd2-9bd8ff16d204 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 67853295-be49-b731-d597-94f59291a90c | Product name | 3 | 20250311 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68083-604-25 | Procainamide Hydrochloride | 25 in 1 CASE | INJECTION, SOLUTION | 25 | 3 | |
| 68083-604-25 | Procainamide Hydrochloride | 2 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 2 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Procainamide Hydrochloride | PROCAINAMIDE HYDROCHLORIDE | Medical Purchasing Solutions, LLC. | 42405567-3d04-7aec-e063-6294a90aba0a | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | 218135 ANDA218135 |
| Procainamide Hydrochloride | PROCAINAMIDE HYDROCHLORIDE | Sagent Pharmaceuticals | 358c956e-8c6c-4bd6-a6bc-194d5b3d6d9a | 2024-12-18 | Boxed warning, Warnings, Adverse reactions | 218135 ANDA218135 |
| Procainamide Hydrochloride | PROCAINAMIDE HYDROCHLORIDE | Gland Pharma Limited | ffde440f-7ad7-434c-bcd2-9bd8ff16d204 | 2024-07-23 | Boxed warning, Warnings, Adverse reactions | 218135 ANDA218135 68083-604-25 68083-604 68083060425 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 857886 | procainamide HCl 100 MG/ML Injectable Solution | PSN | ffde440f-7ad7-434c-bcd2-9bd8ff16d204 | 3 |
| 857962 | procainamide HCl 500 MG/ML Injectable Solution | PSN | ffde440f-7ad7-434c-bcd2-9bd8ff16d204 | 3 |
| 857886 | procainamide hydrochloride 100 MG/ML Injectable Solution | SCD | ffde440f-7ad7-434c-bcd2-9bd8ff16d204 | 3 |
| 857962 | procainamide hydrochloride 500 MG/ML Injectable Solution | SCD | ffde440f-7ad7-434c-bcd2-9bd8ff16d204 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 68083-604-25 | 68083060425 | 25 VIAL, MULTI-DOSE in 1 CASE (68083-604-25) / 2 mL in 1 VIAL, MULTI-DOSE | 2024-07-22 | No | No | Current |